Guardian Capital (Canada)’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$129K Sell
8,700
-2,900
-25% -$861K ﹤0.01% 168
2025
Q4
$115K Sell
11,600
-700
-6% -$190K ﹤0.01% 159
2025
Q3
$143K Sell
12,300
-300
-2% -$81.6K ﹤0.01% 150
2025
Q2
$166K Hold
12,600
0.01% 139
2025
Q1
$48.7K Buy
12,600
+300
+2% +$74K ﹤0.01% 144
2024
Q4
$18.8K Buy
+12,300
New +$2.83M ﹤0.01% 140
2023
Q1
Sell
-188
Closed -$400K 161
2022
Q4
$400K Buy
188
+4
+2% +$695 0.01% 149
2022
Q3
$568K Sell
184
-1
-0.5% -$198 0.02% 148
2022
Q2
$534K Buy
185
+10
+6% +$2.12K 0.02% 150
2022
Q1
$273K Buy
+175
New +$41.1K 0.01% 169

Other funds holding CME

Guardian Capital (Canada)'s CME Position: Q1 2026 in Review

Guardian Capital (Canada) reduced its CME Group (CME) stake by 30% in Q1 2026, selling an estimated $3.53M and leaving 27,200 shares worth $8.03M. The position accounts for 0.21% of the portfolio, ranked #76.

Guardian Capital (Canada) first reported a position in CME in Q4 2014 and has held it in 42 quarters since. The position peaked at $15.1M in Q3 2019. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Guardian Capital (Canada) held 27,200 shares of CME Group worth $8.03M as of Q1 2026.
  • Guardian Capital (Canada) sold 11,900 CME Group shares in Q1 2026, an estimated $3.53M.
  • CME Group made up 0.21% of Guardian Capital (Canada)'s portfolio in Q1 2026, its #76 holding.
  • Guardian Capital (Canada) first reported a position in CME Group in Q4 2014 and has held it in 42 quarters since.
  • Guardian Capital (Canada)'s CME Group position peaked at $15.1M in Q3 2019.
  • 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Guardian Capital (Canada)'s 13F filing for Q1 2026, filed 15 May 2026.